A detailed history of M. Kraus & CO transactions in Johnson & Johnson stock. As of the latest transaction made, M. Kraus & CO holds 53,376 shares of JNJ stock, worth $8.62 Million. This represents 2.62% of its overall portfolio holdings.

Number of Shares
53,376
Previous 53,914 1.0%
Holding current value
$8.62 Million
Previous $8.53 Million 8.52%
% of portfolio
2.62%
Previous 2.84%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$144.38 - $157.78 $77,676 - $84,885
-538 Reduced 1.0%
53,376 $7.8 Million
Q1 2024

Apr 10, 2024

BUY
$155.22 - $162.74 $39,270 - $41,173
253 Added 0.47%
53,914 $8.53 Million
Q4 2023

Jan 10, 2024

SELL
$145.6 - $158.88 $69,305 - $75,626
-476 Reduced 0.88%
53,661 $8.41 Million
Q3 2023

Oct 16, 2023

SELL
$155.75 - $174.48 $677,512 - $758,988
-4,350 Reduced 7.44%
54,137 $8.43 Million
Q2 2023

Jul 14, 2023

BUY
$154.35 - $166.11 $47,076 - $50,663
305 Added 0.52%
58,487 $9.68 Million
Q1 2023

Apr 18, 2023

BUY
$151.05 - $180.26 $215,397 - $257,050
1,426 Added 2.51%
58,182 $9.02 Million
Q4 2022

Jan 25, 2023

BUY
$160.2 - $179.79 $343,148 - $385,110
2,142 Added 3.92%
56,756 $0
Q3 2022

Oct 27, 2022

BUY
$161.33 - $179.52 $63,725 - $70,910
395 Added 0.73%
54,614 $8.92 Million
Q2 2022

Jul 15, 2022

BUY
$168.19 - $186.01 $11,436 - $12,648
68 Added 0.13%
54,219 $9.62 Million
Q1 2022

Apr 18, 2022

BUY
$158.14 - $179.59 $51,395 - $58,366
325 Added 0.6%
54,151 $9.6 Million
Q4 2021

Jan 19, 2022

BUY
$155.93 - $173.01 $92,466 - $102,594
593 Added 1.11%
53,826 $9.21 Million
Q3 2021

Oct 18, 2021

BUY
$161.5 - $179.47 $114,342 - $127,064
708 Added 1.35%
53,233 $8.6 Million
Q2 2021

Jul 21, 2021

BUY
$159.48 - $171.07 $172,078 - $184,584
1,079 Added 2.1%
52,525 $8.65 Million
Q1 2021

Apr 19, 2021

BUY
$153.07 - $170.48 $84,188 - $93,764
550 Added 1.08%
51,446 $8.46 Million
Q4 2020

Jan 13, 2021

BUY
$137.11 - $157.38 $268,735 - $308,464
1,960 Added 4.01%
50,896 $8.01 Million
Q3 2020

Oct 09, 2020

BUY
$140.38 - $153.83 $133,641 - $146,446
952 Added 1.98%
48,936 $7.29 Million
Q2 2020

Jul 23, 2020

BUY
$128.81 - $155.51 $106,010 - $127,984
823 Added 1.75%
47,984 $6.75 Million
Q1 2020

Apr 14, 2020

SELL
$111.14 - $153.99 $31,119 - $43,117
-280 Reduced 0.59%
47,161 $6.18 Million
Q4 2019

Jan 15, 2020

BUY
$127.5 - $146.44 $33,150 - $38,074
260 Added 0.55%
47,441 $6.92 Million
Q3 2019

Oct 10, 2019

BUY
$126.95 - $142.14 $252,122 - $282,290
1,986 Added 4.39%
47,181 $6.1 Million
Q2 2019

Jul 17, 2019

BUY
$131.15 - $144.24 $96,526 - $106,160
736 Added 1.66%
45,195 $6.3 Million
Q1 2019

Apr 15, 2019

BUY
$125.72 - $139.79 $13,200 - $14,677
105 Added 0.24%
44,459 $6.22 Million
Q4 2018

Jan 15, 2019

SELL
$122.84 - $147.84 $5,896 - $7,096
-48 Reduced 0.11%
44,354 $5.72 Million
Q3 2018

Oct 23, 2018

BUY
$121.58 - $142.88 $49,239 - $57,866
405 Added 0.92%
44,402 $6.14 Million
Q2 2018

Jul 11, 2018

BUY
$119.4 - $131.76 $597 - $658
5 Added 0.01%
43,997 $5.34 Million
Q1 2018

Apr 19, 2018

BUY
$125.1 - $148.14 $70,681 - $83,699
565 Added 1.3%
43,992 $5.64 Million
Q4 2017

Jan 18, 2018

SELL
$131.22 - $143.62 $58,392 - $63,910
-445 Reduced 1.01%
43,427 $6.07 Million
Q3 2017

Oct 17, 2017

BUY
$129.47 - $135.38 $5.68 Million - $5.94 Million
43,872
43,872 $5.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $422B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track M. Kraus & CO Portfolio

Follow M. Kraus & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kraus & CO, based on Form 13F filings with the SEC.

News

Stay updated on M. Kraus & CO with notifications on news.